cover image: ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE (TRIUMEQ 600 MG-50 MG-300MG TAB)  - Please visit the link below if you require our standard special authorization form:

20.500.12592/2wqn96

ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE (TRIUMEQ 600 MG-50 MG-300MG TAB) - Please visit the link below if you require our standard special authorization form:

17 May 2023

• combined use of more than one biologic DMARD will not be reimbursed) Claim notes: • Must be prescribed by a rheumatologist or internist • Approvals will be for a maximum of 40mg every two weeks • Initial Approval: 6 months. [...] Hidradenitis suppurative (HS) For the treatment of patients with moderate to severe hidradenitis suppurative who have not responded to conventional therapy (including systemic antibiotics) and who meet all of the following: • A total absess and nodule count of 3 or greater • Lesions in at least two distinct anatomic areas, one of which must be Hurley Stage II or III • An inadequate response to a 9. [...] For adolescent or adult patients in whom epiphyseal closure has occurred and who met the listingcriteria above, treatment should be discontinued if any of the following occur: • hyperparathyroidism, or • nephrocalcinosis, or • evidence of fracture or pseudofracture based on radiographic assessment. [...] Treatment should be discontinued if there is evidence of; • Sustained loss of virologic suppression (as defined above); OR • Development of resistance to, adverse events leading to lack of tolerability of, and/or lack of adherence to either component of the drug regimen; Claim Notes: • The patient must be under the care of a practitioner experienced in the care of patients with HIV. [...] Advanced Hepatocellular Carcinoma For the second-line treatment of adult patients with unresectable hepatocellular carcinoma who meet all of the following criteria: • Disease progression on sorafenib or lenvatinib • Child-Pugh class status of A • ECOG performance status of 0 or 1 Renewal Criteria: • Written confirmation that the patient has responded to treatment and continues to experience clinic.
Pages
390
Published in
Canada

Tables